Patents Assigned to Japan as Represented by the President of National Cardiovascular Center
  • Patent number: 8323881
    Abstract: A method of injecting cells into a biological tissue comprising thrusting injection needle (200) under microvibration into tissue (5) secured by suction to tissue suction means (210) and effecting injection of a cell suspension into the tissue through the needle. There is also provided an apparatus for cell injection into the biological tissue.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: December 4, 2012
    Assignees: Japan as represented by President of National Cardiovascular Center, Nipro Corporation
    Inventors: Toshiya Fujisato, Akio Kishida, Soichiro Kitamura
  • Patent number: 7910360
    Abstract: An apparatus and method for inoculating a biological substrate with cells include provision for rotating a container in which the substrate and a cell suspension are received about first and second axes of rotation. The apparatus comprises said container, first drive means for rotatably supporting the container about the first axis, and second drive means for rotatably supporting the first drive means about the second axis. The first and second axes of rotation do not lie in the same plane and extend in different directions so that the container revolves around the second axis while the container is rotating about the first axis. The inoculation method utilizes this apparatus.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: March 22, 2011
    Assignees: JAPAN as represented by PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER, Nipro Corporation
    Inventors: Toshiya Fujisato, Takuro Kogoshi, Yusuke Suga, Akio Kishida, Takeshi Nakatani, Soichiro Kitamura
  • Patent number: 7883864
    Abstract: A method of efficiently removing or fixing donor cells from a native tissue of mammalian origin comprises immersing the tissue in a treating solution, and irradiating the tissue with microwave while maintaining the temperature thereof in the range between 0° C. and 40° C.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: February 8, 2011
    Assignees: Japan as represented by President of National Cardiovascular Center, Nipro Corporation
    Inventors: Toshiya Fujisato, Akio Kishida, Seiichi Funamoto, Takeshi Nakatani, Soichiro Kitamura
  • Publication number: 20100248255
    Abstract: The present invention provides novel peptides with circulation-modulating activity. These peptides are useful as circulation-modulating agents and vasopressors because of their circulation-modulating activity, and can be used for treating diseases of the circulatory system such as myocardial infarction, ischemic heart disease, cerebral infarction, or the like.
    Type: Application
    Filed: July 28, 2006
    Publication date: September 30, 2010
    Applicants: KYOWA HAKKO KOGYO CO., LTD, JAPAN AS REPRESENTED BY THE PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER, OSAKA UNIVERSITY
    Inventors: Motoo Yamasaki, Noriyuki Takahashi, Naoto Minamino, Kazuki Sasaki, Toshifumi Takao, Yoshinori Satomi
  • Publication number: 20100143310
    Abstract: The invention provides a spinal neuron damage treating agent for use in the treatment of spinal neuron damage, or an agent for promoting the proliferation of spinal neuronal precursor cells in the culture of spinal neuronal precursor cells, or an agent for promoting the regeneration of spinal nerves after transplantation of cultured spinal neuronal precursor cells, and the like. The invention provides an agent that contains a substance (e.g., ghrelin) that acts on the growth hormone secretagogue-receptor as an active ingredient, the agent being a spinal neuron damage treating agent for use in the treatment of spinal neuron damage, or an agent for promoting the proliferation of cultured spinal neuronal precursor cells in the culture of spinal neuronal precursor cells, or an agent for promoting the regeneration of spinal nerves after transplantation of cultured spinal neuronal precursor cells, and the like.
    Type: Application
    Filed: August 10, 2007
    Publication date: June 10, 2010
    Applicant: JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER
    Inventors: Noboru Murakami, Keiko Nakahara, Miho Hashimoto, Yujiro Hayashi, Kenji Kangawa
  • Patent number: 7718763
    Abstract: The present invention relates to specific substrates for a von Willebrand factor cleaving enzyme, ADAMTS-13, as well as to diagnosis of ADAMTS-13 deficient patients, diagnostic compositions, and kits employing the substrates. Particularly preferable substrate polypeptides for ADAMTS-13 are the polypeptide which begins at amino acid 1587 and ends at amino acid 1668 of SEQ ID NO: 1 in the Sequence Listing, and the polypeptide which begins at amino acid 1596 and ends at amino acid 1668 of SEQ ID NO: 1 in the Sequence Listing. These substrate polypeptides for ADAMTS-13 have high substrate specificity and also superior quantitativeness, and a suitable size for production by recombinant methods.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: May 18, 2010
    Assignee: Japan as Represented by the President of National Cardiovascular Center
    Inventors: Toshiyuki Miyata, Koichi Kokame
  • Patent number: 7611782
    Abstract: A reactive functional group is introduced into titanium oxide, and an active group which is capable of reacting with the reactive functional group is introduced into a polymer-based material, and the reactive functional group and the active group are reacted with each other, thereby producing a titanium oxide complex in which the polymer-based material and the titanium oxide chemically bond to each other. Further, a functional group of the polymer-based material and the titanium oxide are reacted with each other, thereby producing the titanium oxide complex without performing chemical pretreatment with respect to the titanium oxide.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: November 3, 2009
    Assignee: Japan as Represented by the President of National Cardiovascular Center
    Inventors: Tsutomu Furuzono, Akio Kishida
  • Publication number: 20080319502
    Abstract: A micro integrated cardiac pacemaker includes a control unit for outputting a control signal according to cardiograph information, heart stimulating means for stimulating heart tissue in response to the control signal, cardiograph information extracting means for extracting cardiograph information and outputting it to the control unit, and a power supply unit for supplying drive power. The power supply unit is a biological fuel cell that takes out electrons by oxidation of a biological fuel. The biological fuel cell includes an anode and a cathode. An oxidase of a biological fuel and a mediator are immobilized on the cathode. Blood and/or body fluid are used as an electrolytic solution, and a biological fuel and oxygen in the blood and/or the fluid are used. The biological fuel cell is attached to the end of a catheter and implanted into the heart, and the catheter is withdrawn, without incising the breast.
    Type: Application
    Filed: April 15, 2008
    Publication date: December 25, 2008
    Applicants: JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER, FUJIKIN INCORPORATED
    Inventors: Kenji SUNAGAWA, Masaru SUGIMACHI, Masashi INAGAKI
  • Publication number: 20080300642
    Abstract: The cell viability in cell transplantation is improved so as to achieve sufficient repair of organ. There is provided a regeneration treatment apparatus comprising: a heart rate detector which detects a heart rate of a patient; a memory part which stores a heart rate prior to stimulation; stimulating electrodes which stimulate a vagus nerve that controls an organ having transplanted cells; and a control unit which controls an intensity of a stimulation signal to be output from the stimulating electrodes to the vagus nerve so that the heart rate of the patient detected by the heart rate detector is decreased by 5 to 20% as compared to the state prior to the stimulation.
    Type: Application
    Filed: May 29, 2008
    Publication date: December 4, 2008
    Applicants: JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER, OLYMPUS CORPORATION
    Inventors: Masashi INAGAKI, Masaru SUGIMACHI, Meihua LI, Can ZHENG, Masatoshi KOBAYASHI, Kazuo SHIMIZU
  • Publication number: 20080215107
    Abstract: A medical treating system based on biological activities characterized by biological activity sensing means for sensing biological activity information produced by biological activities and outputting a biological activity signal, calculating means for receiving, analyzing, and processing the biological activity signals from the biological activity sensing means, calculating an organism stimulation signal, and outputting the organism stimulation signal, and organism stimulating means for receiving the organism stimulation signal calculated by the calculating means and stimulating an organism according to the organism stimulation signal. A cardiac pacing system based on the treating system, a blood pressure regulating system, and a cardiac disease treating system are also disclosed.
    Type: Application
    Filed: April 16, 2008
    Publication date: September 4, 2008
    Applicants: JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER, FUJIKIN INCORPORATED
    Inventors: Kenji SUNAGAWA, Masaru SUGIMACHI, Takayuki SATO
  • Publication number: 20080139958
    Abstract: A practical method for estimating cardiac output and pulmonary artery wedge pressure with good accuracy is provided. The present invention provides a method for estimating the impedance arising from solid tissue by determining the impedance at the intersection between the line of identity and the extrapolated regression line, where the regression line is obtained by linearly regressing the maximum value to the minimum value of the impedance signal of each of multiple data sets, where each data set contains the maximum value and the minimum value of the impedance signal during one cardiac cycle, where impedance signal is obtained between a can electrode implanted in the left thoracic wall and an electrode inserted into the coronary vein, over a specific period of time following the infusion of hypertonic saline into the pulmonary circulation.
    Type: Application
    Filed: December 4, 2007
    Publication date: June 12, 2008
    Applicants: JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CARDIOVASCULAR CENTER, OLYMPUS CORPORATION
    Inventors: Kazunori UEMURA, Masashi INAGAKI, Masaru SUGIMACHI, Kazuo SHIMIZU, Masatoshi KOBAYASHI
  • Publication number: 20070176699
    Abstract: A particle beam generator has a vacuum chamber, a magnet which generates a constant magnetic field in the vacuum chamber, acceleration electrodes which generates a magnetic field in a direction perpendicular to the direction of the magnetic field generated by the magnet in the vacuum chamber, a take-out electrode which takes out charged particles accelerated in the vacuum chamber; and a target cell provided at a position at which the charged particles taken out by the taken-out electrode strikes. At least a part of surfaces exposed to the charged particles of the vacuum chamber, the acceleration electrodes, the take-out electrode and/or the target cell is made of a material including an element having atomic number larger than copper.
    Type: Application
    Filed: March 29, 2005
    Publication date: August 2, 2007
    Applicants: Japan as Represented by the President of National Cardiovascular Center, Molecular Imaging Laboratory, Inc. c/o Institute of Biomedical Research and Innovation
    Inventors: Hidehiro Iida, Toru Inomata, Mamoru Fujimara, Iwao Miura, Toshihiro Ota
  • Publication number: 20050288718
    Abstract: A medical treating system based on biological activities characterized by biological activity sensing means for sensing biological activity information produced by biological activities and outputting a biological activity signal, calculating means for receiving, analyzing, and processing the biological activity signals from the biological activity sensing means, calculating an organism stimulation signal, and outputting the organism stimulation signal, and organism stimulating means for receiving the organism stimulation signal calculated by the calculating means and stimulating an organism according to the organism stimulation signal. A cardiac pacing system based on the treating system, a blood pressure regulating system, and a cardiac disease treating system are also disclosed.
    Type: Application
    Filed: August 5, 2002
    Publication date: December 29, 2005
    Applicant: Japan as Represented by President of National Cardiovascular Center
    Inventors: Kenji Sunagawa, Masaru Sugimachi, Takayuki Sato